首页|期刊导航|食品工业科技|刺梨纳米囊泡的制备、表征及其抗氧化、降血糖与抗毒溶血活性研究

刺梨纳米囊泡的制备、表征及其抗氧化、降血糖与抗毒溶血活性研究OA

Preparation,Characterization of Rosa roxburghii Tratt.Nanovesicles and Its Antioxidant,Hypoglycemic,and Antihemolytic Activities

中文摘要英文摘要

为深入研究刺梨来源纳米囊泡(Rosa roxburghii Tratt.-derived nanovesicles,RDNs)的结构特征及其活性,对其进行分离提取及表征,并探究其抗氧化、降血糖及抗金黄色葡萄球菌(Staphylococcus aureus,S.aureus)外毒素溶血活性.采用超速差速离心法提取RDNs,通过透射电镜(TEM)观察形态,结合BCA法、薄层色谱法和RNA提取等方法分别检测蛋白质、脂质和RNA的成分及浓度.利用DPPH和ABTS+自由基清除体系评估抗氧化能力,检测RDNs对α-葡萄糖苷酶和α-淀粉酶的抑制能力以评估降血糖活性,以 2%大鼠红细胞为研究对象,将实验分为空白对照组、阳性对照组、S.aureus-EVs(S.aureus-derived extracellular vesicles)组、RDNs组和RDNs+S.aureus-EVs组,检测RDNs的体外抗溶血率.结果表明,RDNs平均粒径为 155.27±1.39 nm,Zeta电位为−8.60±0.64 mV,−80℃保存 12 d稳定,4℃保存 6 d以内稳定,超过 6 d则粒径显著变化(P<0.01),pH为 1.2时粒径无显著变化(P>0.05),pH为 6.5时粒径变化显著(P<0.05);RDNs含蛋白质(5.50±0.00 mg/mL)、脂质(4.23±0.40 mg/mL)和RNA(3.91±1.97 μg/mL),蛋白分布于 24、50~70、70 kDa,脂质类成分复杂,其中含有植物甾醇类和卵磷脂类.在 0~212.30 mg/mL范围内,RDNs对DPPH、ABTS+自由基的清除效果与浓度呈正相关,且其对两种自由基的半抑制浓度(IC50)分别为 112.90和 64.38 mg/mL,此外,当浓度为 212.30 mg/mL时,RDNs对ABTS+自由基的清除率可达 99.80%;对α-葡萄糖苷酶和α-淀粉酶的抑制率分别为 48%和 21%,但其活性显著低于阳性药组(P<0.01);RDNs组溶血率趋近于 0,S.aureus-EVs组溶血率为 64%,RDNs+S.aureus-EVs组溶血率为 8%,显著低于S.aureus-EVs组(P<0.01).刺梨纳米囊泡具有抗氧化、降血糖活性且能发挥抗S.aureus外毒素溶血的作用,为其在抗氧化领域和天然抗菌剂领域的潜在应用奠定了基础.

To deeply investigate the structural characteristics and activities of nanovesicles derived from Rosa roxburghii Tratt.(RDNs),they were isolated,extracted,and characterized.Additionally,their antioxidant,hypoglycemic,and anti-hemolytic activities against Staphylococcus aureus exotoxin were explored.The RDNs were isolated using ultracentrifugation,and their morphology was characterized through transmission electron microscopy(TEM).The protein,lipid,and RNA composition/concentrations were quantified employing the BCA assay,thin-layer chromatography(TLC),and RNA extraction kits,respectively.The antioxidant capacity was assessed using DPPH and ABTS+radical scavenging assays,while the hypoglycemic activity was evaluated through α-glucosidase and α-amylase inhibition assays.Using 2%rat erythrocytes as the research object,the experiment was divided into blank control group,positive control group,S.aureus-EVs group,RDNs group,and RDNs+S.aureus-EVs group,and in vitro anti-hemolytic rate of RDNs was detected.The results indicated that RDNs had an average hydrodynamic diameter of 155.27±1.39 nm,a Zeta potential of −8.60±0.64 mV,and maintained stability at −80℃for 12 days.The particles remained stable during the first 6 days of storage at 4℃,but exhibited significant particle size changes after surpassing the 6-day mark(P<0.01).Particle size remained unchanged(P>0.05)at pH1.2,while pH6.5 showed significant change in particle size(P<0.05).Biochemical analysis uncovered the presence of protein(5.50±0.00 mg/mL),lipid(4.23±0.40 mg/mL),and RNA(3.91±1.97 μg/mL).Notably,protein bands were observed at 24,50~70,and 70 kDa.Lipid components exhibited an intricate composition,which included phytosterols and lecithins.Concentration-dependent(0~212.30 mg/mL)scavenging of DPPH and ABTS+radicals was observed,with the half-inhibitory concentrations(IC50)for the two radicals being 112.90 and 64.38 mg/mL,respectively.Additionally,when the concentration reached 212.30 mg/mL,the RDNs were capable of eliminating 99.80%of ABTS+.The α-glucosidase and α-amylase inhibition rates were 48%and 21%,respectively,significantly lower than positive controls(P<0.01).The hemolysis rates were nearly 0 in the RDNs group,64%in the S.aureus-EVs group,and 8%in the RDNs+S.aureus-EVs group,which was significantly lower than that in the S.aureus-EVs group(P<0.01).The RDNs had antioxidant and hypoglycemic activities and could exert anti-hemolytic effects against S.aureus exotoxins,laying a foundation for their potential applications in the fields of antioxidants and natural antibacterial agents.

曹明未;庞玉新;魏永耀;王甜甜;邓芳雪;刘炳楠;刘畅

贵州中医药大学药学院,贵州 贵阳 550025贵州中医药大学药学院,贵州 贵阳 550025广东药科大学药学院,广东 广州 510006贵州中医药大学药学院,贵州 贵阳 550025贵州中医药大学药学院,贵州 贵阳 550025贵州中医药大学药学院,贵州 贵阳 550025贵州中医药大学药学院,贵州 贵阳 550025

轻工纺织

刺梨纳米囊泡生物活性金黄色葡萄球菌外毒素

Rosa roxburghii Tratt.nanovesiclesbioactivityStaphylococcus aureusexotoxin

《食品工业科技》 2026 (8)

153-161,9

国家中医药管理局高水平重点学科建设项目(zyyzdxk-2023186)贵州省正品药材种质资源库设备建设项目(正品药材优势特色产业集群(中药材产业集群))(3411-411000163)贵州中医药大学喀斯特药用资源保护与创新利用科技创新人才团队项目(GZYTDHezi[2022]001)贵州省中医药管理局中医药、民族医药科学技术研究课题(QZYY-2025-071).

10.13386/j.issn1002-0306.2025040349

评论